NSCLC, RECURRENT
Clinical trials for NSCLC, RECURRENT explained in plain language.
Never miss a new study
Get alerted when new NSCLC, RECURRENT trials appear
Sign up with your email to follow new studies for NSCLC, RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo aims to outsmart tough lung cancers
Disease control Recruiting nowThis study is testing whether adding an oral drug called pirfenidone to an existing immunotherapy (atezolizumab) can help control advanced non-small cell lung cancer that has come back or spread after initial treatments. It will involve about 25 adults to first check safety and t…
Matched conditions: NSCLC, RECURRENT
Phase: PHASE1, PHASE2 • Sponsor: University of Kansas Medical Center • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC
-
Smart cell therapy aims to target advanced cancers while sparing healthy tissue
Disease control Recruiting nowThis study is testing a new type of personalized cell therapy for adults with advanced solid tumors that have come back or spread. The therapy, called Tmod CAR T, is designed to recognize and kill cancer cells while using a built-in safety switch to protect the patient's healthy …
Matched conditions: NSCLC, RECURRENT
Phase: PHASE1, PHASE2 • Sponsor: A2 Biotherapeutics Inc. • Aim: Disease control
Last updated Mar 12, 2026 13:52 UTC